New Hope for Postpartum Depression

4 days ago
4 min read

Postpartum depression (PPD) affects approximately 1 in 7 new mothers, making it one of the most common complications following childbirth. While many women experience the temporary "baby blues," postpartum depression is a more serious medical condition that can interfere with maternal well-being, sleep, bonding with a newborn, and overall quality of life.

Traditional treatment typically includes psychotherapy and antidepressant medications such as selective serotonin reuptake inhibitors (SSRIs). However, researchers are increasingly exploring another important contributor to postpartum depression: dysregulation of the autonomic nervous system, particularly persistent activation of the body's stress response.

A New Study Examines SGB for Postpartum Depression

A recently published study in the American Journal of Translational Research compared ultrasound-guided stellate ganglion block (SGB) with escitalopram (Lexapro) in 98 women diagnosed with postpartum depression. Researchers evaluated depression severity, sleep quality, stress hormone levels, and overall treatment response.

The investigators found that women treated with SGB experienced:

Greater improvement in depression symptoms
Better sleep quality
Lower levels of stress hormones including cortisol, ACTH, and CRH
A higher overall treatment success rate compared with the medication group

These findings suggest that treating the body's stress response may represent an important therapeutic avenue for postpartum depression.

Why Might SGB Help?

Although postpartum depression is influenced by many biological, psychological, and social factors, researchers increasingly recognize that an overactive sympathetic ("fight-or-flight") nervous system may contribute to symptoms in some individuals.

A stellate ganglion block temporarily interrupts sympathetic nervous system activity, allowing the nervous system an opportunity to reset. While the procedure is best known for its use in PTSD, complex regional pain syndrome (CRPS), and other sympathetically mediated conditions, researchers are now exploring its role in a growing number of disorders involving autonomic nervous system dysfunction.

The improvements in both mood and stress hormone levels observed in this study support the theory that reducing excessive sympathetic activity may help improve symptoms in appropriately selected patients.

Important Limitations

While these findings are encouraging, they should be interpreted carefully.

This was a retrospective study, meaning researchers analyzed patients who had already received treatment rather than randomly assigning participants to different therapies. Because of this design, the study cannot establish that the stellate ganglion block was solely responsible for the improvements observed.

Larger randomized controlled trials are still needed to better determine the effectiveness, long-term outcomes, and safety of stellate ganglion block for postpartum depression. The study authors acknowledge these limitations and recommend additional research before widespread adoption.

The Bigger Picture

One of the most exciting aspects of this study extends beyond postpartum depression itself.

For decades, many mental health treatments have focused primarily on neurotransmitters and brain chemistry. Today, a growing body of research is expanding that perspective to include the autonomic nervous system and its role in conditions involving chronic stress, trauma, anxiety, hyperarousal, PTSD, and potentially postpartum depression.

As our understanding of the nervous system continues to evolve, treatments that help regulate autonomic function may become an increasingly important part of comprehensive mental health care.

What Does This Mean for Patients?

Although stellate ganglion block is not currently considered a standard treatment for postpartum depression, studies like this continue to improve our understanding of how regulating the nervous system may influence mood and recovery.

For women whose symptoms may involve significant autonomic nervous system dysregulation, future research may help clarify whether SGB has a role alongside established treatments such as psychotherapy, medication, lifestyle interventions, and social support.

As always, treatment decisions should be individualized and made in partnership with a qualified healthcare professional.

If you would like to learn more about Neuro Sympathetic Reset (NSR), our advanced approach to stellate ganglion block (SGB), we invite you to explore the information on this page.

If you or someone you know is interested in this treatment, please complete our intake form to receive your complimentary assessments. Our compassionate team will carefully review your information, answer any questions you may have, and reach out to discuss whether NSR may be an appropriate treatment option for your unique situation.

Original Research

Yang H, et al. Ultrasound-guided stellate ganglion block versus escitalopram in the treatment of postpartum depression: a retrospective study. American Journal of Translational Research. 2025;17(3):2305-2312.

Read the full open-access study here: https://pmc.ncbi.nlm.nih.gov/articles/PMC11982829/

This article is intended for educational purposes only and should not be considered medical advice. If you believe you may be experiencing postpartum depression, please seek evaluation from your healthcare provider. If you are experiencing thoughts of harming yourself or your baby, seek emergency medical care immediately.

— Michael J. Louwers, MD

Board-Certified Physical Medicine & Rehabilitation

Interventional Pain Medicine • Trauma-Informed Nervous System Care

CEO and Medical Director, Reset Medical & Wellness Center